than larger LDL subpopulations. We aimed to assess which LDL subtype is observed in ESRD patients on HD, as well as to evaluate the relationship between lipoprotein subclasses and LDL oxidation. METHODS: We evaluated, in 112 ESRD patients on HD and 22 controls (matched for gender and, as far as possible, for age), oxLDL, the lipid profile and the lipoprotein subclasses. RESULTS: ESRD patients, as compared to controls, presented higher TG and oxLDL/ LDL ratio, and lower TC, LDLc and oxLDL. In ESRD patients, the percentages of verylow-density lipoprotein (VLDL) and of intermediate-density lipoprotein (IDL) were higher, while the larger LDL subclasses were lower, as compared to controls. OxLDL correlated positively with TC, TG, LDLc, the percentage of VLDL, intermedium and small LDL, and LDL size; oxLDL/LDL correlated positively with the percentage of small LDL and negatively with the percentage of large LDL. CONCLUSIONS: In spite of the low LDLc observed in ESRD, LDL particles are more atherogenic; we found increased LDL oxidation within LDL particles, diminishment of larger LDL (the less atherogenic LDL subfraction); the atherogenic changes in LDL particles alongside with the increase in the percentage of VLDL and IDL, may contribute to the higher CV risk. The atherogenic nature of LDL particles in ESRD patients on HD warrants further studies on its value as a marker of risk for CV events. 
INTRODUCTION AND AIMS:
Smoking is a well-known risk factor for renal function decline. However, the risk of CKD development in nonsmokers exposed to secondhand smoke is not well elucidated yet. This study aimed to investigate the association between secondhand smoking and the risk of CKD development among never-smoking adults. METHODS: Subjects who participated in the Korean Genome and Epidemiology Study (KoGES) from 2001 to 2014 were enrolled. A total of 4856 subjects with normal renal function and without a history of smoking were included in the final analysis. The subjects were divided into two groups depending on secondhand smoke exposure (SSE). The primary outcome was development of CKD defined as estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m 2 .
RESULTS:
In the SSE and non-SSE groups, the mean ages of the subjects were 49.5 6 7.4 and 51.6 6 7.9 years, the numbers of male subjects were 289 (14.0) and 466 (16.7), and the mean estimated glomerular filtration rates (eGFR) were 95.1 6 12.7 and 93.9 6 12.8 ml/min/1.73 m 2 , respectively. Among the subjects in the SSE group, the duration of SSE showed a significant positive correlation with BMI and HbA1c. Cox analysis revealed that SSE was a significant risk of CKD development even after adjustments were made for confounding factors (Hazard ratio, 1.15; 95% confidence interval, 1.02-1.33; P ¼ 0.049). CONCLUSIONS: Secondhand smoking significantly increased the risk of CKD development. In addition, factors such as obesity and insulin resistance may be affected by SSE. Avoiding SSE may have an effect on preventing the development of CKD. In patients with pre-existing kidney disease, high FGF23 levels are associated with kidney disease progression and premature mortality. However, it is unclear whether FGF23 is also associated with incident CKD and mortality in members of the general population without pre-existing kidney disease. We therefore investigated these potential associations in the general population-based Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort. METHODS: Total (C-terminal ) FGF was measured by ELISA in plasma samples of 4171 subjects with no prior history of CKD. Samples were collected between 2001 and 2003. Incident CKD was defined as new-onset eGFR < 60ml/min*1.73m2 or 24-hour urinary albumin excretion > 30mg. Data is shown as mean6SD or median [IQR] .
Associations between FGF23, incident CKD, and all-cause mortality were studied using Cox proportional hazards regression. RESULTS: Median age was 50 In sensitivity analyses, the association of FGF23 with incident CKD also remained when the eGFR and the UAE endpoint were analyzed separately (fully adjusted model: P¼0.04 and P¼0.002, respectively). CONCLUSIONS: In the general population, in subjects without pre-existing CKD, high levels of FGF23 are associated with increased risk for both incident CKD and allcause mortality, independent of baseline renal function, markers of bone and mineral status, and traditional cardiovascular risk factors. Future studies should investigate whether FGF23 may be of added value in predictive models for the development of CKD or mortality in the general population. 
INTRODUCTION AND AIMS:
Obesity is a risk factor for incident chronic kidney disease (CKD) in the general population. However, not all the published studies showed an association between BMI and progression of kidney disease in patients with CKD. C1q / TNF related protein 1 (CTRP1) is a new adipokine with anti-atherogenic and anti-inflammatory effects and may have a regulatory role in the association between obesity and vascular diseases. The aim of the study is to reveal any link between CTRP1 levels and CKD progression. METHODS: Patients with stage 3 and 4 CKD without previous cardiovascular events were included and divided into two groups according to BMI. Demographic data and measurements of CTRP1, renal function, albuminuria, lipid study, diabetes, C-reactive protein, aldosterone, plasma renin, urinary sodium and concomitant medication were collected at baseline. During the follow-up renal events (defined as dialysis entry, creatinine duplication or 50% drop in estimated glomerular filtration rate [MDRD4]) were registered.
RESULTS: 71 patients with CKD were divided into two groups: 25 obese (BMI> 30 kg / m2) and 46 non-obese. CTRP1 in plasma at baseline was higher in obese patients (342 6 141 vs 433 6 246 ng/ml, p ¼ 0.041). No significant association was found between CTRP1 levels and CKD stage, presence of diabetes, aldosterone and renin levels, or blood pressure. The obese had higher systolic blood pressure (p ¼ 0.018) and higher CRP (p ¼ 0.019) and uric (p ¼ 0.003) levels, without significant differences in percentage of diabetes or albuminuria. During a mean follow-up of 63.7 months, 14 patients had a renal event. Patients with CTRP1 in the lowest tertile had more renal events, both in the overall sample (logRank: 5.810, p ¼ 0. 
